Unitrin Inc. Reports Operating Results (10-Q)

Author's Avatar
May 07, 2012
Unitrin Inc. (UTR, Financial) filed Quarterly Report for the period ended 2012-03-31.

Unitrin Inc. has a market cap of $1.61 billion; its shares were traded at around $0 with a P/E ratio of 11.6 and P/S ratio of 0.6. The dividend yield of Unitrin Inc. stocks is 3.5%.

Highlight of Business Operations:

Earned Premiums in the Life and Health Insurance segment decreased by $1.4 million for the three months ended March 31, 2012, compared to the same period in 2011, due primarily to lower life insurance and property insurance earned premiums, partially offset by higher accident and health insurance earned premiums. Earned premiums on life insurance decreased by $0.9 million in 2012 due primarily to lower volume of insurance. Earned premiums on property insurance decreased by $0.8 million in 2012 due primarily to lower volume of insurance from the run-off and non-renewal of dwelling coverage. Earned premiums on accident and health insurance increased by $0.3 million in 2012 due primarily to higher average premium and higher volume of supplemental health insurance products, partially offset by lower volume of insurance resulting from the suspension of sales of certain health insurance products described below and lower volume of Medicare supplement insurance.

Approximately 41%, or $17.1 million, of the Life and Health Insurance segment s accident and health insurance earned premiums for the three months ended March 31, 2012 were derived from health insurance products that may be adversely impacted by the Patient Protection and Affordable Care Act (“PPACA”), compared to 44%, or $18.1 million, in 2011. At the end of 2011, Reserve National Insurance Company (“Reserve National”) suspended sales of such affected health insurance products. During 2011, Reserve National also began transitioning its sales to other health insurance products that are not expected to be as severely impacted by PPACA. There can be no assurance that the transition will fully offset the impact from suspending sales of the affected health insurance products.

Read the The complete Report